A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Hoffmann-La Roche
Boston, MA · +93 more sites
22 recruiting crohn's disease studies with a site in Boston, MA.
Sponsor: Hoffmann-La Roche
Boston, MA · +93 more sites
Sponsor: Sanofi
Boston, MA · +19 more sites
Sponsor: Merck Sharp & Dohme LLC
Boston, MA · +86 more sites
Sponsor: Eli Lilly and Company
Boston, MA · Waltham, MA · +9 more sites
Sponsor: Eli Lilly and Company
Boston, MA · +14 more sites
Sponsor: Massachusetts General Hospital
Boston, MA
Sponsor: National Cancer Institute (NCI)
Boston, MA · +49 more sites
Sponsor: Massachusetts General Hospital
Boston, MA
Sponsor: Janssen Research & Development, LLC
Boston, MA · +13 more sites
Sponsor: Sanofi
Boston, MA · Worcester, MA · +123 more sites
Sponsor: University of North Carolina, Chapel Hill
Boston, MA · +10 more sites
Sponsor: Boston Children's Hospital
Boston, MA · +1 more sites
Sponsor: Connecticut Children's Medical Center
Boston, MA · +21 more sites
Sponsor: Weill Medical College of Cornell University
Boston, MA · +5 more sites
Sponsor: Takeda
Boston, MA · +21 more sites
Sponsor: Takeda
Boston, MA · +21 more sites
Sponsor: Massachusetts General Hospital
Boston, MA
Sponsor: Massachusetts General Hospital
Boston, MA
Sponsor: Massachusetts General Hospital
Boston, MA
Sponsor: Boston Children's Hospital
Boston, MA
Sponsor: Brigham and Women's Hospital
Boston, MA
Sponsor: Brigham and Women's Hospital
Boston, MA
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.